- 中文名稱
綿羊來(lái)源多克隆抗體：Connexin-40（254-270）/Cx40/254 antisera：whole serum
- 英文名字
- Sheep antibody to Connexin-40 (254-270)/Cx40/254 antisera: whole serum
- 供應(yīng)商
- Biosensis
- 產(chǎn)品貨號(hào)
- S-063-100
- 產(chǎn)品報(bào)價(jià)
- ￥詢價(jià)/100uL
- 產(chǎn)品說(shuō)明書(shū)
- 點(diǎn)擊查看
- 購(gòu)買(mǎi)方式
- Biosensis中國(guó)區(qū)現(xiàn)貨中心已經(jīng)建立，大部分產(chǎn)品中國(guó)有現(xiàn)貨庫(kù)存。銀行轉(zhuǎn)賬、電匯、支票、現(xiàn)金，在線支付寶及網(wǎng)銀支付，或直接與我們電話聯(lián)系400-6800-868
- 產(chǎn)品新聞
- 背景資料
- Biosensis品牌專注于神經(jīng)科學(xué)領(lǐng)域的抗體和試劑的開(kāi)發(fā)，在神經(jīng)科學(xué)領(lǐng)域?qū)儆谌蝾I(lǐng)航者，被廣泛用于阿爾茨海默氏癥（AD）、帕金森氏癥（PD）和肌萎縮側(cè)索硬化（ALS）疾病，以及自噬和代謝應(yīng)激障礙的研究。武漢艾美捷科技作為Biosensis品牌中國(guó)區(qū)域總代理，提供Biosensis品牌特色的組織染色方案：FJC退化神經(jīng)元染色試劑盒、病理髓鞘染色試劑盒、淀粉樣斑塊染色試劑等。武漢艾美捷科技擁有獨(dú)立的專業(yè)銷(xiāo)售團(tuán)隊(duì)、技術(shù)支持團(tuán)隊(duì)、市場(chǎng)營(yíng)銷(xiāo)團(tuán)隊(duì)、進(jìn)出口報(bào)關(guān)團(tuán)隊(duì)，可以為您提供及時(shí)的咨詢響應(yīng)，專業(yè)的產(chǎn)品和解決方案支持，穩(wěn)健快捷的交貨周期，優(yōu)質(zhì)放心的售后服務(wù)。我們致力于為您提供有價(jià)值的產(chǎn)品和服務(wù)，在意您的成功！
- 應(yīng)用類(lèi)型
- WB; IF, Frozen;
Immunohistochemistry: Antibody detects Cxn 40 in rat tissues and arterial endothelial cells. The authors report that the density of Cx40 plaques was significantly greater in the caudal artery (CA) than in the thoracic aorta (ThA), whereas no such difference was seen for Cx37 and Cx43. Expression of Cx40 was absent from the media of both thoracic and caudal artery tissues (see Rummery, NM et al 2002 for more staining specifics).
Published Method: Unfixed 10 μm thick sections cryosections or lightly fixed (2% paraformaldehyde in 0.1 mol/L sodium phosphate buffer) whole mount sections have been tested, see Rummery, NM et al 2002). Pretreatments include pre-incubation for 30 minutes in a blocking solution of 2% bovine serum albumin (BSA), 0.2% Triton-X in PBS, followed by primary antibody incubation. Antibody was used at 1:100 to 1:250 for 1 hour in the original work but Biosensis recommends optimizing the conditions for the best results. Original detection was via Cy3- conjugated anti-goat immunoglobulins (Jackson Immunoresearch Laboratories Inc, PA, 1:100) in 0.01% Triton-X in PBS, but other secondary conditions should work as well once optimized. In the original work the specificity of each antibody was tested by incubation either without primary antibody or with primary antibody that had previously been pre-incubated for 1 hour at room temperature with 10-fold excess by weight of the peptide against which the antibody was raised. (Adapted from Rummery, NM et al 2002).
Western Blot: Antibody is not recommended for western blots by Biosensis, however, it does react in westerns with Cxn 40 specific material. The authors report that the antibody develops numerous bands in westerns blots, only some of which are removed upon peptide treatment (see Rummery, NM et al 2002). The Cx40/254 antibody specifically recognized a band of 40 kDa from lung, caudal artery (CA), and thoracic aorta (ThA) but not liver (online Figure VIIA, +/- peptide). In the lung, however, a band at 45 kDa also appeared to be reduced with Cxn 40 peptide addition.
Published Method: Brain, heart, liver, lung, thoracic aorta and caudal arteries were removed from 5-6 week old Wistar rats and snap frozen in liquid nitrogen Tissues were ground under liquid nitrogen in a mortar and pestle and resuspended in 1mL of lysis buffer (1 mM NaHCO3 pH 7.05, 10 mM EDTA, 10 mM Iodoacetamide, 10 mM tetra-sodium pyrophosphate, 1 mM PMSF and 1 μg/mL each of antipain, aprotinin, pepstatin-A, chymostatin and leupeptin). Tissues were further disrupted by grinding in a polytron blender. Unbroken cells and large debris were removed by centrifugation at 1000 g for 5 minutes at 4oC, the supernatant was then removed and centrifuged at 3000 g for 5 minutes. The pellet was discarded, and the supernatant centrifuged at 20000 g for 15 minutes at 4°C. The supernatant was discarded, and the membrane-enriched pellet was resuspended in lysis buffer. Protein concentration was measured using the Bio-Rad protein assay kit. Membrane-bound connexins were subsequently solubilized by incubation in 2x SDS sample buffer (5% SDS, 125 mM Tris-Cl (pH 6.8), 20% glycerol, 2 mM _- mercaptoethanol, 0.1% (w/v) bromophenol blue) for 60 minutes at 37°C. Aliquots containing 5 μg of protein were separated by SDS-PAGE on 12% polyacrylamide gels and blotted onto PVDF membranes. Blots were probed with sheep antibodies against Cx40 (1:1000, Cx40/254) and detected via ECL using anti-Goat poly HRP secondary antibodies 1:4000, 1 hr. (adapted from Rummery, NM et al 2002).Biosensis recommends optimal dilutions/concentrations should be determined by the end user.
- 免疫原
- A synthetic peptide consisting of amino acids 254 to 270 of the C-terminus of rat Cx40 (Cx40/254) conjugated to diphtheria toxoid has been used as the immunogen.
- 來(lái)源宿主
- 綿羊
- 反應(yīng)性
- reported that the Cx40/254 antibody did not cross react with 大鼠 Cx43 but may with Cx45 in Western blots only (Rummery, NM et al 2002).
- 保存建議
- 廠家建議常溫運(yùn)輸。抗體溶解之后，建議分裝保存于-20℃。當(dāng)保存于4℃時(shí)，應(yīng)添加適量的抗生素。按照1:1體積比添加最高純度的甘油，可增加抗體的穩(wěn)定性。請(qǐng)避免反復(fù)凍融。
- 其他
- Biosensis專注于神經(jīng)科學(xué)領(lǐng)域的抗體和試劑的開(kāi)發(fā)，特別是神經(jīng)營(yíng)養(yǎng)因子和神經(jīng)營(yíng)養(yǎng)因子受體。 近30年來(lái)，Biosensis一直是該領(lǐng)域的全球領(lǐng)航者和OEM供應(yīng)商。除神經(jīng)營(yíng)養(yǎng)因子，我們的神經(jīng)科學(xué)產(chǎn)品組合還被廣泛用于神經(jīng)退行性疾病、神經(jīng)發(fā)育和神經(jīng)代謝的研究。重點(diǎn)研究領(lǐng)域包括阿爾茨海默氏癥（AD）、帕金森氏癥（PD）和肌萎縮側(cè)索硬化（ALS）疾病，以及自噬和代謝應(yīng)激障礙，包括肥胖、代謝綜合征的研究、神經(jīng)免疫學(xué)和炎癥。Biosensis的產(chǎn)品系列不僅包括持續(xù)增長(zhǎng)的神經(jīng)科學(xué)研究抗體系列，還包括200多種定量研究ELISAs試劑盒（1板或2板，自由選擇），組織染色（退化神經(jīng)元染色試劑盒、病理髓鞘染色試劑盒、淀粉樣斑塊染色試劑等）和細(xì)胞可視化試劑（染色）以及針對(duì)神經(jīng)科學(xué)和細(xì)胞疾病研究的純化的蛋白質(zhì)。我們的抗體和試劑已被廣泛應(yīng)用于各種技術(shù)，包括蛋白質(zhì)印跡，免疫組織化學(xué)，流式分析，共聚焦顯微鏡實(shí)時(shí)成像，生物抑制和細(xì)胞培養(yǎng)以及克隆。
- 注意
-
該頁(yè)面的中文產(chǎn)品信息的翻譯，僅供參考。準(zhǔn)確的產(chǎn)品信息請(qǐng)以廠家的英文說(shuō)明書(shū)為準(zhǔn)。下單前，請(qǐng)瀏覽說(shuō)明書(shū)確認(rèn)。
-
